Carbamazepine

Contraindicated

Carbamazepine Cabotegravir Apretude May significantly reduce cabotegravir plasma concentrations and result in loss of virological response. Details Carbamazepine Doravirine Pifeltro Reduced doravirine exposure, reduced efficacy of doravirine and an increased risk of doravirine resistance Details Carbamazepine Fostemsavir Rukobia Reduced temsavir (the active moiety of fostemsavir) exposure and possible loss of virologic response Details Carbamazepine Lenacapavir Injection Sunlenca Reduced lenacapavir exposure which may result in the loss of therapeutic effect and development of resistance to lenacapavir Details Carbamazepine Lenacapavir Oral Sunlenca Reduced lenacapavir exposure which may result in the loss of therapeutic effect and development of resistance to lenacapavir Details Carbamazepine Linezolid Injection Zyvox An increased risk of serotonin syndrome Details Carbamazepine Lurasidone Latuda Reduced lurasidone exposure Details Carbamazepine Nifedipine Adalat® Reduced NIFEdipine exposure and reduced efficacy of NIFEdipine Details

Major

Carbamazepine Acetaminophen And Codeine Capital® & Codeine Explained An increased risk of acetaminophen hepatotoxicity and reduced acetaminophen exposure Details Carbamazepine Clindamycin ANTIROBE Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Carbamazepine Omeprazole Gastrobim Explained Increased carBAMazepine exposure, an increased risk of carBAMazepine toxicity, reduced omeprazole exposure and reduced efficacy of... Details Carbamazepine Amitriptyline Elavil Explained Reduced tricyclic antidepressants exposure and reduced efficacy of tricyclic antidepressants Details Carbamazepine Sertraline Explained Reduced sertraline exposure and an increased risk of serotonin syndrome Details Carbamazepine Buprenorphine Belbuca Explained Reduced buprenorphine exposure, reduced efficacy of buprenorphine, an increased risk of serotonin syndrome and an increased risk o... Details Carbamazepine Relugolix Orgovyx Explained Reduced relugolix exposure and reduced efficacy of relugolix Details Carbamazepine Colchicine Colcrys Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Carbamazepine Simvastatin Flolipid Explained Reduced simvastatin exposure Details Carbamazepine Abemaciclib Verzenio Explained Decreased abemaciclib plasma concentration Details Carbamazepine Abrocitinib Cibinqo Explained Reduced CYP2C9 substrate exposure and reduced efficacy of CYP2C9 substrate Details Carbamazepine Acalabrutinib Calquence Reduced acalabrutinib exposure Details Carbamazepine Acetaminophen Acephen An increased risk of acetaminophen hepatotoxicity and reduced acetaminophen exposure Details Carbamazepine Acetaminophen Injection Acephen An increased risk of acetaminophen hepatotoxicity and reduced acetaminophen exposure Details Carbamazepine Acetaminophen Rectal Acephen An increased risk of acetaminophen hepatotoxicity and reduced acetaminophen exposure Details Carbamazepine Acetazolamide Diamox® Sequels® Increased carBAMazepine exposure Details Carbamazepine Albendazole Albendamax Reduced albendazole exposure Details Carbamazepine Alpelisib Piqray Reduced alpelisib exposure and reduced efficacy of alpelisib Details Carbamazepine Apixaban Eliquis Explained Reduced apixaban exposure, reduced efficacy of apixaban and an increased risk of stroke and other thromboembolic events Details Carbamazepine Apremilast Otezla Reduced apremilast exposure and an reduced efficacy of apremilast Details Carbamazepine Aripiprazole Injection Abilify Reduced ARIPiprazole exposure and an increased risk of respiratory depression, profound sedation, hypotension and syncope Details Carbamazepine Asciminib Scemblix Reduced asciminib exposure and reduced efficacy of asciminib Details Carbamazepine Asenapine Transdermal Patch Secuado An increased risk of CNS depression Details Carbamazepine Atogepant Qulipta Reduced atogepant exposure Details Carbamazepine Avapritinib Ayvakit Reduced avapritinib exposure and reduced efficacy of avapritinib Details Carbamazepine Avatrombopag Doptelet Reduced CYP3A4/CYP2C9 substrate exposure and reduced efficacy of CYP3A4/CYP2C9 substrate Details Carbamazepine Azathioprine Azasan An increased risk of hepatotoxicity Details Carbamazepine Belumosudil Rezurock Explained Reduced belumosudil exposure and reduced efficacy of belumosudil Details Carbamazepine Betrixaban Bevyxxa® Decreased betrixaban exposure Details Carbamazepine Atorvastatin Atorvaliq Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Carbamazepine Cariprazine Vraylar Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Carbamazepine Abiraterone Abirtega Reduced abiraterone exposure and reduced efficacy of abiraterone Details